Matthew Valentine v. HHS - Influenza, acute transverse myelitis and acute disseminated encephalomyelitis (2025)

Filed 2022-08-18Decided 2025-11-20Vaccine Influenza
compensated$150,000

Case summary [AI summaries can sometimes make mistakes]

On August 18, 2022, Matthew Valentine filed a petition alleging that an influenza vaccination administered on September 11, 2019 caused acute transverse myelitis and acute disseminated encephalomyelitis. He was 37 years old at vaccination.

Respondent denied that Mr. Valentine's alleged TM, ADEM, or residual effects were vaccine-caused.

The public stipulation does not describe onset, diagnostic testing, hospitalization, treatment, expert opinions, or the biological mechanism alleged. On November 20, 2025, Chief Special Master Corcoran adopted the parties' stipulation and awarded $150,000.00 as a lump sum through counsel for all damages available under the Vaccine Act.

Theory of causation

Adult petitioner, age 37; influenza vaccine September 11, 2019; alleged acute transverse myelitis and ADEM. COMPENSATED by stipulation. Respondent denied causation; public text lacks clinical chronology, diagnostics, treatment, mechanism, or experts. Decision November 20, 2025. Award $150,000.00 lump sum. Petition filed August 18, 2022.

Source PDFs 1 total · 1 downloaded